|
|
Article: NewCo News: CalciMedica Gains Access To Programs In Calcium Channels.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Staff Writer
CalciMedica Inc. is carving out a niche in the autoimmune and inflammatory field by focusing on calcium release-activated calcium (CRAC) channels, which are critical to the release of interleukin-2, TNF-alpha and other cytokines involved in the immune response.
Back in 2005, scientists at TorreyPines Therapeutics Inc. pinpointed the STIM1 gene as a key connection between the release of stored calcium and the activation of CRAC channels. Not long afterward, scientists at Harvard Medical School's CBR Institute for Biomedical Research Inc. (CBRI) discovered a CRAC channel called Orai1, which is believed to work with STIM1 as a gatekeeper of the ...
Related newspaper, magazine, and journal articles:
|
|
Article: TorreyPines Therapeutics to Present Data at the 8th ...
PR Newswire;
March 15, 2007 ;
700+ words
... ... March 15 /PRNewswire-FirstCall/ -- TorreyPines Therapeutics, Inc. today announced ... D., Chief Scientific Officer of TorreyPines Therapeutics, provides data on a series ... secretase modulator compounds discovered by TorreyPines. These compounds have been shown to ...
|
|